Exact Mass: 500.294

Mupirocin

C26H44O9 (500.2985)

Mupirocin (pseudomonic acid A, or Bactroban or Centany) is an antibiotic originally isolated from Pseudomonas fluorescens. It is used topically, and is primarily effective against Gram-positive bacteria. Mupirocin is bacteriostatic at low concentrations and bactericidal at high concentrations. Mupirocin has a unique mechanism of action, which is selective binding to bacterial isoleucyl-tRNA synthetase, which halts the incorporation of isoleucine into bacterial proteins. Because this mechanism of action is not shared with any other antibiotic, mupirocin has few problems of antibiotic cross-resistance. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Same as: D01076 Mupirocin (BRL-4910A, Pseudomonic acid) is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2].

Laprafylline

C29H36N6O2 (500.29)

C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator

9-[4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]-2-oxiranyl]methyl]-2-oxanyl]-3-methyl-1-oxobut-2-enoxy]nonanoic acid

C26H44O9 (500.2985)

Plukenetione F

C33H40O4 (500.2926)

Tricalysioside T

C26H44O9 (500.2985)

Plukenetione G

C33H40O4 (500.2926)

Acremolide B

C28H40N2O6 (500.2886)

3,15-Dihydroxy-ent-labd-7-en-oic acid 3-O-beta-D-glucoside

C26H44O9 (500.2985)

Hyperibone K

C33H40O4 (500.2926)

ent-8R,13S;15,17-diepoxy-3beta-D-glucopyranosyloxylabdan-14alpha-ol|microtropioside A

C26H44O9 (500.2985)

C26H44O9

C26H44O9 (500.2985)

chrozophorozide A2

C26H44O9 (500.2985)

16-O-beta-D-Glucopyranoside-(ent-3beta, 13xi)-7-Pimarene-3, 15, 16, 18-tetrol

C26H44O9 (500.2985)

1-benzoyl-8,8-dimethyl-3,5-bis(3-methyl-2-butenyl)-6-(2-methylpropenyl)tricyclo[3.3.1.1(3.7)]-decan2-2,4,9-trione|plukenetione A

C33H40O4 (500.2926)

chrozophorozide A

C26H44O9 (500.2985)

garcibracteatone

C33H40O4 (500.2926)

fissistigmatin C

C33H40O4 (500.2926)

ent-2beta,15,16,19-tetrahydroxypimar-8(14)-en-19-O-beta-glucopyranoside

C26H44O9 (500.2985)

(1beta,5beta,8xi,9beta,10alpha,11alpha,14beta)-8,11,14-trihydroxypimar-15-en-1-yl beta-D-glucopyranoside|ent-isopimanervoside A

C26H44O9 (500.2985)

(2beta,3Z,7alpha,8E)-3,8-Dolabelladiene-2,7,16,18-tetrol|chrozophorozide B

C26H44O9 (500.2985)

senedensiscin C

C26H44O9 (500.2985)

12beta,16alpha,17,19-tetrahydroxy-ent-kaurane 19-O-beta-D-glucopyranoside

C26H44O9 (500.2985)

pilosanol C

C26H44O9 (500.2985)

codinaeopsin

C32H40N2O3 (500.3039)

Ala Val Ala Ile Gln

C22H40N6O7 (500.2958)

Mupirocin

C26H44O9 (500.2985)

An alpha,beta-unsaturated ester resulting from the formal condensation of the alcoholic hydroxy group of 9-hydroxynonanoic acid with the carboxy group of (2E)-4-[(2S)-tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoic acid in which the tetrahydropyranyl ring is substituted at positions 3 and 4 by hydroxy groups and at position 5 by a {(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl group. Originally isolated from the Gram-negative bacterium Pseudomonas fluorescens, it is used as a topical antibiotic for the treatment of Gram-positive bacterial infections. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Mupirocin (BRL-4910A, Pseudomonic acid) is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2].

MLS001074711-01!Mupirocin

C26H44O9 (500.2985)

3-Indoleacetic acid (IAA)

C26H44O9 (500.2985)

4-hydroxyglucobrassicin

C26H44O9 (500.2985)

Abscisic Acid

C26H44O9 (500.2985)

Camalexin

C26H44O9 (500.2985)

Gluconapin (3-butenylglucosinolate)

C26H44O9 (500.2985)

Glucoerucin (4-methylthiobutyl glucosinolate)

C26H44O9 (500.2985)

Glucobrassicin (Indol-3-ylmethylglucosinolate)

C26H44O9 (500.2985)

Glucoraphanin (4-methylsulfinylbutyl glucosinolate)

C26H44O9 (500.2985)

Glucoiberin (3-methylsulfinylpropylglucosinolate)

C26H44O9 (500.2985)

Jasmonic acid

C26H44O9 (500.2985)

4-Methoxyglucobrassicin (4-Methoxy-3-indolylmethyl glucosinolate)

C26H44O9 (500.2985)

Neoglucobrassicin (1-Methoxy-3-indolylmethyl glucosinolate)

C26H44O9 (500.2985)

Salicylic Acid

C26H44O9 (500.2985)

Sinalbin (p-Hydroxybenzylglucosinolate)

C26H44O9 (500.2985)

sulforaphane

C26H44O9 (500.2985)

MUPIROCIN_major

C26H44O9 (500.2985)

MUPIROCIN_minor

C26H44O9 (500.2985)

Glu Lys Lys Pro

C22H40N6O7 (500.2958)

Glu Lys Pro Lys

C22H40N6O7 (500.2958)

Glu Pro Lys Lys

C22H40N6O7 (500.2958)

Ile Ile Gln Gln

C22H40N6O7 (500.2958)

Ile Leu Gln Gln

C22H40N6O7 (500.2958)

Ile Gln Ile Gln

C22H40N6O7 (500.2958)

Ile Gln Leu Gln

C22H40N6O7 (500.2958)

Ile Gln Gln Ile

C22H40N6O7 (500.2958)

Ile Gln Gln Leu

C22H40N6O7 (500.2958)

Lys Glu Lys Pro

C22H40N6O7 (500.2958)

Lys Glu Pro Lys

C22H40N6O7 (500.2958)

Lys Lys Glu Pro

C22H40N6O7 (500.2958)

Lys Lys Pro Glu

C22H40N6O7 (500.2958)

Lys Pro Glu Lys

C22H40N6O7 (500.2958)

Lys Pro Lys Glu

C22H40N6O7 (500.2958)

Leu Ile Gln Gln

C22H40N6O7 (500.2958)

Leu Leu Gln Gln

C22H40N6O7 (500.2958)

Leu Gln Ile Gln

C22H40N6O7 (500.2958)

Leu Gln Leu Gln

C22H40N6O7 (500.2958)

Leu Gln Gln Ile

C22H40N6O7 (500.2958)

Leu Gln Gln Leu

C22H40N6O7 (500.2958)

Pro Glu Lys Lys

C22H40N6O7 (500.2958)

Pro Lys Glu Lys

C22H40N6O7 (500.2958)

Pro Lys Lys Glu

C22H40N6O7 (500.2958)

Gln Ile Ile Gln

C22H40N6O7 (500.2958)

Gln Ile Leu Gln

C22H40N6O7 (500.2958)

Gln Ile Gln Ile

C22H40N6O7 (500.2958)

Gln Ile Gln Leu

C22H40N6O7 (500.2958)

Gln Leu Ile Gln

C22H40N6O7 (500.2958)

Gln Leu Leu Gln

C22H40N6O7 (500.2958)

Gln Leu Gln Ile

C22H40N6O7 (500.2958)

Gln Leu Gln Leu

C22H40N6O7 (500.2958)

Gln Gln Ile Ile

C22H40N6O7 (500.2958)

Gln Gln Ile Leu

C22H40N6O7 (500.2958)

Gln Gln Leu Ile

C22H40N6O7 (500.2958)

Gln Gln Leu Leu

C22H40N6O7 (500.2958)

AVAIQ

C22H40N6O7 (500.2958)

GLSPK

C22H40N6O7 (500.2958)

tris[2-[2-(2-methoxyethoxy)ethoxy]ethyl] orthoborate

C21H45BO12 (500.3004)

lithium,9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate

C26H44O9 (500.2985)

4-[bis(5-cyclohexyl-4-hydroxy-2-methylphenyl)methyl]benzene-1,2-diol

C33H40O4 (500.2926)

4-Chloro-2,6-dimethoxypyrimidine

C26H44O9 (500.2985)

1,3,5,7-tetrakis(4-aminophenyl)adamantane

C34H36N4 (500.294)

9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid

C26H44O9 (500.2985)

9-[(E)-3-methyl-4-[(2S,3R,4S,5R)-3,4,5-trihydroxy-5-[(E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]but-2-enoyl]oxynonanoic acid

C26H44O9 (500.2985)

9-[4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]-2-oxiranyl]methyl]-2-oxanyl]-3-methyl-1-oxobut-2-enoxy]nonanoic acid

C26H44O9 (500.2985)

2-[(1S,3S,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide

C27H40N4O5 (500.2999)

2-[(1S,3S,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide

C27H40N4O5 (500.2999)

2-[(1R,3R,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide

C27H40N4O5 (500.2999)

2-[(1R,3S,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide

C27H40N4O5 (500.2999)

2-[(1S,3R,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide

C27H40N4O5 (500.2999)

2-[(1R,3R,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide

C27H40N4O5 (500.2999)

2-[(1R,3S,4aS,9aR)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide

C27H40N4O5 (500.2999)

2-[(1S,3R,4aR,9aS)-6-[[(cyclopentylamino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide

C27H40N4O5 (500.2999)

(16R,17S)-8-(4-Morpholinyl)-17-[2-(4-morpholinyl)-2-oxoethyl]-12-oxa-1,4-diazatricyclo[14.3.1.06,11]icosa-6,8,10-trien-2-one

C27H40N4O5 (500.2999)

MGMG 17:3

C26H44O9 (500.2985)

LPEth 21:4

C26H45O7P (500.2903)

LPM 22:4

C26H45O7P (500.2903)

ST 20:0;O4;Hex

C26H44O9 (500.2985)

2-({4-hydroxy-1-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(1s,3r,5r,7s,8r)-5-benzoyl-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)-8-(2-methylprop-1-en-1-yl)adamantane-2,4,9-trione

C33H40O4 (500.2926)

1-(5-hydroxy-3-methylpentyl)-5,5,8a-trimethyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylic acid

C26H44O9 (500.2985)

5-benzoyl-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)-8-(2-methylprop-1-en-1-yl)adamantane-2,4,9-trione

C33H40O4 (500.2926)

2-{[14,15-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(1s,9r,11r)-9-benzoyl-4,4,10,10-tetramethyl-1,11-bis(3-methylbut-2-en-1-yl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione

C33H40O4 (500.2926)

(2r,3r,4s,5s,6r)-2-{[(4r,4ar,4br,5r,7s,8r,8ar,10ar)-7-ethenyl-5,8,8a-trihydroxy-1,1,4a,7-tetramethyl-decahydrophenanthren-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

3,13-clerodadiene-6,15,16,19-tetrol; (ent-6β,13z)-form,19-o-beta-d-glucopyranoside

C26H44O9 (500.2985)

{"Ingredient_id": "HBIN006924","Ingredient_name": "3,13-clerodadiene-6,15,16,19-tetrol; (ent-6\u03b2,13z)-form,19-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C26H44O9","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8455","PubChem_id": "NA","DrugBank_id": "NA"}

9-benzoyl-4,4,10,10-tetramethyl-1,11-bis(3-methylbut-2-en-1-yl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione

C33H40O4 (500.2926)

(1r,3s,5r,7r,8s)-5-benzoyl-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)-8-(2-methylprop-1-en-1-yl)adamantane-2,4,9-trione

C33H40O4 (500.2926)

(1s,9r,11s)-9-benzoyl-4,4,10,10-tetramethyl-1,11-bis(3-methylbut-2-en-1-yl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione

C33H40O4 (500.2926)

2-{[12-hydroxy-10-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-12a-methyl-6-methylidene-1h,2h,3h,3ah,4h,5h,7h,8h,9h,12h-cyclopenta[11]annulen-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

2-{[7-ethenyl-5,8a-dihydroxy-4a-(hydroxymethyl)-1,1,7-trimethyl-decahydrophenanthren-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(1s,3s,5r,7s,8s)-1-benzoyl-6,6-dimethyl-3,5-bis(3-methylbut-2-en-1-yl)-8-(2-methylprop-1-en-1-yl)adamantane-2,4,9-trione

C33H40O4 (500.2926)

(2s,3r,4s,5s,6r)-2-{[(1s,2r,4s,4ar,8ar)-4-hydroxy-1-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(2r,3r,4s,5s,6r)-2-[(2r)-2-[(2s,4ar,4bs,6s,7s,8as)-6,7-dihydroxy-2,4b,8,8-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

1-benzoyl-4,4,12,12-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione

C33H40O4 (500.2926)

2-({14-hydroxy-5,5,9,13-tetramethyl-16,18-dioxatetracyclo[11.4.1.0¹,¹⁰.0⁴,⁹]octadecan-6-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

2-{2-hydroxy-2-[7-hydroxy-8-(hydroxymethyl)-2,4b,8-trimethyl-3,4,4a,5,6,7,8a,9-octahydro-1h-phenanthren-2-yl]ethoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(1s,4as,6r,8as)-1-[(3s)-5-hydroxy-3-methylpentyl]-5,5,8a-trimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylic acid

C26H44O9 (500.2985)

(2r,3r,4s,5s,6r)-2-{[(3r,3as,7r,12s,12as)-12-hydroxy-10-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-12a-methyl-6-methylidene-1h,2h,3h,3ah,4h,5h,7h,8h,9h,12h-cyclopenta[11]annulen-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

4-[8a-methyl-4-methylidene-6-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]-5,7,8-trimethoxy-2-phenyl-4h-chromene

C33H40O4 (500.2926)

2-{[12-hydroxy-10-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-6,12a-dimethyl-1h,2h,3h,3ah,4h,7h,8h,9h,12h-cyclopenta[11]annulen-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(2s,3r,4s,5s,6r)-2-({2-[(1r,3as,4s,9r,12as)-4,9-dihydroxy-6-(hydroxymethyl)-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-1-yl]propan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(3s,5s,6s,9s,14as)-9-benzyl-5,7-dihydroxy-6-methyl-3-[(2r)-7-oxooctan-2-yl]-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

C28H40N2O6 (500.2886)

(2r,3r,4s,5s,6r)-2-[(2r)-2-[(2s,4ar,4bs,6s,7r,8as)-6,7-dihydroxy-2,4b,8,8-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

2-[(7-ethenyl-5,8,8a-trihydroxy-1,1,4a,7-tetramethyl-decahydrophenanthren-4-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

9-benzyl-5,7-dihydroxy-6-methyl-3-(7-oxooctan-2-yl)-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

C28H40N2O6 (500.2886)

(1r,9s,11s)-1-benzoyl-4,4,12,12-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione

C33H40O4 (500.2926)

(2r,3r,4s,5s,6r)-2-[(2s)-2-[(2s,4ar,4bs,7s,8s,8as)-7-hydroxy-8-(hydroxymethyl)-2,4b,8-trimethyl-3,4,4a,5,6,7,8a,9-octahydro-1h-phenanthren-2-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(1r,3s,5r,7s,8r)-1-benzoyl-6,6-dimethyl-3,5-bis(3-methylbut-2-en-1-yl)-8-(2-methylprop-1-en-1-yl)adamantane-2,4,9-trione

C33H40O4 (500.2926)

2-[2-(6,7-dihydroxy-2,4b,8,8-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-3h-phenanthren-2-yl)-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(4r)-4-[(1s,4as,6r,8as)-8a-methyl-4-methylidene-6-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]-5,7,8-trimethoxy-2-phenyl-4h-chromene

C33H40O4 (500.2926)

2-({2-[4,9-dihydroxy-6-(hydroxymethyl)-3a-methyl-10-methylidene-1h,2h,3h,4h,7h,8h,9h,11h,12h,12ah-cyclopenta[11]annulen-1-yl]propan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(1s,9r,11s)-1-benzoyl-4,4,12,12-tetramethyl-9,11-bis(3-methylbut-2-en-1-yl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione

C33H40O4 (500.2926)

(2s,3r,4s,5s,6r)-2-{[(4ar,4bs,5s,7r,8ar,9s,10as)-7-ethenyl-5,8a-dihydroxy-4a-(hydroxymethyl)-1,1,7-trimethyl-decahydrophenanthren-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(1s,4as,6r,8ar)-1-[(3s)-5-hydroxy-3-methylpentyl]-5,5,8a-trimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylic acid

C26H44O9 (500.2985)

(2r,3r,4s,5s,6r)-2-{[(3r,3as,7s,12s,12as)-12-hydroxy-10-(hydroxymethyl)-3-(2-hydroxypropan-2-yl)-6,12a-dimethyl-1h,2h,3h,3ah,4h,7h,8h,9h,12h-cyclopenta[11]annulen-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

(3s,3ar,4s,6as,10s,15s,17ar)-1,15-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,14h,15h,16h-cyclotrideca[d]isoindol-17-one

C32H40N2O3 (500.3039)

(1s,3r,5s,7s,8r)-5-benzoyl-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)-8-(2-methylprop-1-en-1-yl)adamantane-2,4,9-trione

C33H40O4 (500.2926)

(9r,14as)-9-benzyl-5,7-dihydroxy-6-methyl-3-(7-oxooctan-2-yl)-3h,4h,5h,6h,9h,12h,13h,14h,14ah-pyrrolo[2,1-c]1-oxa-4,7-diazacyclododecane-1,10-dione

C28H40N2O6 (500.2886)

(2r,3r,4s,5s,6r)-2-{[(1s,4s,6r,9r,10s,13r,14s)-14-hydroxy-5,5,9,13-tetramethyl-16,18-dioxatetracyclo[11.4.1.0¹,¹⁰.0⁴,⁹]octadecan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

19-hydroxy-4,4,16-trimethyl-14,17-bis(3-methylbut-2-en-1-yl)hexacyclo[10.6.1.1¹,¹⁴.0³,¹².0⁵,¹⁰.0¹⁶,¹⁹]icosa-5,7,9-triene-11,13,20-trione

C33H40O4 (500.2926)

(1s,3r,12r,14r,16s,17r,19r)-19-hydroxy-4,4,16-trimethyl-14,17-bis(3-methylbut-2-en-1-yl)hexacyclo[10.6.1.1¹,¹⁴.0³,¹².0⁵,¹⁰.0¹⁶,¹⁹]icosa-5,7,9-triene-11,13,20-trione

C33H40O4 (500.2926)

(2r,3r,4s,5r,6r)-2-{[(1s,4r,5s,9s,10r,13s,14s,15s)-14,15-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O9 (500.2985)

1,15-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,14h,15h,16h-cyclotrideca[d]isoindol-17-one

C32H40N2O3 (500.3039)